Contributors

Abeer M. Al-Ghananeem, Ph.D. College of Pharmacy, University of Kentucky, Lexington, Kentucky, U.S.A.

Paul J. Atkins, Ph.D. Oriel Therapeutics, Inc., Research Triangle Park, North Carolina, U.S.A.

Andrew R. Clark, Ph.D. Nektar Therapeutics, Inc., San Carlos, California, U.S.A.

Peter A. Crooks, Ph.D. College of Pharmacy, University of Kentucky, Lexington, Kentucky, U.S.A.

Timothy M. Crowder, Ph.D. Oriel Therapeutics, Inc., Research Triangle Park, North Carolina, U.S.A.

Michelle Dawson Department of Chemical Engineering, Johns Hopkins University, Baltimore, Maryland, U.S.A.

Myrna B. Dolovich, P.Eng. Departments of Medicine and Radiology, McMaster University, Hamilton, Ontario, Canada

David A. Edwards, Ph.D. Department of Engineering and Applied Science, Harvard University, Cambridge, Massachusetts, U.S.A.

Jennifer Fiegel Department of Chemical Engineering, Johns Hopkins University, Baltimore, Maryland, U.S.A.

W. H. Finlay, Ph.D. Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada

Igor Gonda, Ph.D. Acrux Limited, West Melbourne, Victoria, Australia

Justin Hanes, Ph.D. Department of Chemical Engineering, Johns Hopkins University, Baltimore, Maryland, U.S.A.

Yah-el Har-el Department of Chemical Engineering, Johns Hopkins University, Baltimore, Maryland, U.S.A.

Anthony J. Hickey, Ph.D., D.Sc. School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, U.S.A.

F. Charles Hiller, M.D. University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.

G√ľnther Hochhaus, Ph.D. Department of Pharmaceutics, University of Florida, Gainesville, Florida, U.S.A.

Manish Issar Department of Pharmaceutics, University of Florida, Gainesville, Florida, U.S.A.

Patricia Khan Department of Pharmaceutics, University of Florida, Gainesville, Florida, U.S.A.

Keng H. Leong, Ph.D. Diodetec, Allison Park, Pennsylvania, U.S.A.

Jonathan Man Department of Engineering and Applied Science, Harvard University, Cambridge, Massachusetts, U.S.A.

Cary Mobley Department of Pharmaceutics, University of Florida, Gainesville, Florida, U.S.A.

A. Bruce Montgomery Corus Pharma Inc., Seattle, Washington, U.S.A.

Ralph Niven, Ph.D. Discovery Laboratories, Inc., Redwood City, California, U.S.A.

Christophe Sirand BLM Associates, Inc., Greenwich, Connecticut, U.S.A.

Junghae Suh Department of Chemical Engineering, Johns Hopkins University, Baltimore, Maryland, U.S.A.

David C. Thompson, Ph.D. School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado, U.S.A.

Nicolas Tsapis Department of Engineering and Applied Science, Harvard University, Cambridge, Massachusetts, U.S.A.

Andre X. Valente Department of Engineering and Applied Science, Harvard University, Cambridge, Massachusetts, U.S.A.

Jean-Pierre Varlet Valois S.A., Le Neubourg, France

Dennis M. Williams, Pharm.D. School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, U.S.A.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook


Post a comment